Search
You have no items in your shopping cart.
Close
MEMBER PORTAL
Close

Welcome to the Pharmacy Direct Member Portal

The Member Portal section will allow you to upload prescriptions, pay your Pharmacy Direct account, change your delivery address or chat to one of our agents.

To continue to this section we require your Medical Aid member details which may include dependent details, delivery address and contact details.

If you consent to providing these details, please click on the continue button below.

Thank you.

Accu-Check Smartguide

Diabetic Care

The Accu-Chek SmartGuide is a continuous glucose monitoring (CGM) solution that provides real-time glucose readings and uses artificial intelligence (AI) to predict future glucose levels. The system is designed to help users proactively manage their diabetes by predicting potential highs and lows.
Manufacturer: Roche
SKU: 1241748001
R845,25
- +

Wearable sensor and two integrated apps work together to monitor your glucose levels and predict where they are going

  • Accu-Chek® SmartGuide sensor in a disposable, all-in-one sensor applicator for simple sensor application
  • Comfortable and water-resistant sensor
  • Wireless data transfer to the CGM app every five minutes
  • 14-day wear time

 

Check your real-time CGM values, monitor your diabetes, and record insulin and carbohydrates. Being able to see your CGM data helps you learn how your lifestyle and therapy affect your glucose levels

  • Logbook to record insulin, meals, and more
  • Customisable glucose alarms, so corrective action can be taken to avoid an excursion
  • Graphics and statistics to help patients learn about their diabetes

 

Proven sensor accuracy

With a MARD of 9.2%1 our solution has proven accuracy – therefore your patients have reliable information about their glucose levels2

It has a particularly high accuracy of 7.0 mg/dl MAD under 70 mg/dl 1 

 

1. MARD 9.2% Data on file Roche Diabetes Care
2. The Accu-Chek® SmartGuide Predict app predicts the general estimated glucose development within the next 2 hours (Glucose Predict), the estimated high risk of low glucose within the next 30 minutes (Low Glucose Predict), and the estimated risk of a night-time hypo for the upcoming 7 hours (Night Low Predict, active between 21:00 and 02:00)
3. Compared to the overall MARD of the AccuChek SmartGuide solution
4. Data on file Roche Diabetes Care
5. Calibration as requested by the SmartGuide app is required. Only after calibration can the data be used for insulin dosing decisions

VirtualCare Button